New York State Common Retirement Fund’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12
Closed -$245 3410
2023
Q2
$245 Sell
12
-957
-99% -$29.5K ﹤0.01% 3395
2023
Q1
$26.1K Hold
969
﹤0.01% 3092
2022
Q4
$34.3K Hold
969
﹤0.01% 3132
2022
Q3
$219K Buy
969
+464
+92% +$114K ﹤0.01% 2741
2022
Q2
$95K Sell
505
-2
-0.4% -$403 ﹤0.01% 3088
2022
Q1
$126K Buy
507
+1
+0.2% +$158 ﹤0.01% 2971
2021
Q4
$79K Sell
506
-3
-0.6% -$580 ﹤0.01% 3141
2021
Q3
$102K Sell
509
-386
-43% -$91.8K ﹤0.01% 3135
2021
Q2
$229K Buy
895
+8
+0.9% +$2K ﹤0.01% 2993
2021
Q1
$236K Buy
887
+164
+23% +$51.7K ﹤0.01% 2775
2020
Q4
$267K Buy
723
+193
+36% +$55.4K ﹤0.01% 2632
2020
Q3
$129K Hold
530
﹤0.01% 2826
2020
Q2
$153K Hold
530
﹤0.01% 2769
2020
Q1
$108K Sell
530
-270
-34% -$86.1K ﹤0.01% 2745
2019
Q4
$358K Hold
800
﹤0.01% 2455
2019
Q3
$246K Hold
800
﹤0.01% 2667
2019
Q2
$254K Buy
+800
New +$277K ﹤0.01% 2704
2017
Q2
Sell
-180
Closed -$62K 3253
2017
Q1
$62K Hold
180
﹤0.01% 3041
2016
Q4
$63K Hold
180
﹤0.01% 3033
2016
Q3
$72K Hold
180
﹤0.01% 3042
2016
Q2
$107K Buy
+180
New +$109K ﹤0.01% 2967

Other funds holding EIGR

New York State Common Retirement Fund's EIGR Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q3 2023, closing a stake of 12 shares — an estimated $245 sold.

New York State Common Retirement Fund first reported a position in EIGR in Q2 2016 and held it in 21 quarters. The position peaked at $358K in Q4 2019. 51 funds tracked by Wall St. Rank hold EIGR as of Q3 2023.

  • New York State Common Retirement Fund reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 12 Eiger BioPharmaceuticals, Inc. shares in Q3 2023, an estimated $245.
  • New York State Common Retirement Fund first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2016 and held it in 21 quarters.
  • New York State Common Retirement Fund's Eiger BioPharmaceuticals, Inc. position peaked at $358K in Q4 2019.
  • 51 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.